Likewise, ILR screening was associated with a significant risk reduction of stroke/SE/cardiovascular death only among participants with NT-proBNP >15 pmol/L (HR 0.70 [95% CI, 0.53–0.94]) but not among those with lower levels (HR 1.11 [95% CI, 0.79–1.55]; Pinteraction=0.045). Here, NPPB is linked to Stroke.